Nashville Biosciences

The AI engine Fit Assessment

Beta

NashBio effectively leverages machine learning and pattern discovery to advance the development of personalized therapeutics and diagnostics.

Blurb

NashBio provides real world genomics & bioinformatics resources for drug & diagnostics R&D. We make complex healthcare data easy to use.

HQ Location

Nashville (United States)

Founded

2018

Employees

17

Total funding raised

Not available

Last Funding Event

Not available

Smart insights

  • Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
  • Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
  • 6m headcount growth: 25%
  • 1Y headcount growth: 94%
  • Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
  • Genomic Data Analysis

Operator of a clinical big data, genomics and medical imaging company intended to accelerate the R&D activity of partners in the biopharmaceutical, diagnostics, and AI industries. The company harnesses extensive genomic and bioinformatics resources for drug and diagnostics discovery and development, from a comprehensive genetic database linked to de-identified medical records of longitudinal clinical data to provide clinical insight, resources, and expertise to a wide range of R&D challenges.